BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16220307)

  • 1. The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study.
    Chang TC; Yen TC; Li YT; Wu YC; Chang YC; Ng KK; Jung SM; Wu TI; Lai CH
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):156-63. PubMed ID: 16220307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients.
    Sironi S; Picchio M; Mangili G; Garavaglia E; Zangheri B; Messa C; Voci C; Taccagni GL; del Maschio A; Fazio F
    Gynecol Oncol; 2003 Oct; 91(1):226-30. PubMed ID: 14529686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia.
    Mapelli P; Mangili G; Picchio M; Gentile C; Rabaiotti E; Giorgione V; Spinapolice EG; Gianolli L; Messa C; Candiani M
    Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):505-13. PubMed ID: 23314259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis detection with 18 FDG-positron emission tomography/computed tomography in gestational trophoblastic neoplasia: a report of 2 cases.
    Cortés-Charry R; Figueira LM; Nieves L; Colmenter L
    J Reprod Med; 2006 Nov; 51(11):897-901. PubMed ID: 17165437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective.
    Mangili G; Bergamini A; Giorgione V; Picchio M; Petrone M; Mapelli P; Rabaiotti E; Incerti E; Candiani M
    Q J Nucl Med Mol Imaging; 2016 Jun; 60(2):103-16. PubMed ID: 26868372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of F-18 fluorodeoxyglucose positron emission tomography and computed tomography in molar pregnancy before evacuation.
    Ak I; Ozalp S
    J Reprod Med; 2009 Jul; 54(7):441-6. PubMed ID: 19691261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal stromal tumours: correlation of F-FDG gamma camera-based coincidence positron emission tomography with CT for the assessment of treatment response--an AGITG study.
    Goldstein D; Tan BS; Rossleigh M; Haindl W; Walker B; Dixon J
    Oncology; 2005; 69(4):326-32. PubMed ID: 16293972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental-site trophoblastic tumor and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
    Çerçi SS; Erdemoglu E; Bozkurt KK; Yalçn Y; Erdemoglu E
    Hell J Nucl Med; 2015; 18(3):264-7. PubMed ID: 26574698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography in gynecologic cancer.
    Yen TC; Lai CH
    Semin Nucl Med; 2006 Jan; 36(1):93-104. PubMed ID: 16356798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG PET in small-cell cervical cancer: a prospective study with long-term follow-up.
    Chen MY; Chou HH; Liu FY; Chen CY; Lin G; Yang LY; Pan YB; Jung SM; Wu RC; Huang YT; Tsai JC; Yen TC; Lai CH; Chang TC
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):663-74. PubMed ID: 26519293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
    Dennis K; Hay JH; Wilson DC
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary epithelioid trophoblastic tumor with a synchronous breast carcinoma detected only with FDG-PET/CT Scan.
    Kara T; Ozcan Kara P; Baba F; Celik C; Kara Gedik G
    Rev Esp Med Nucl; 2011; 30(6):368-71. PubMed ID: 21440960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 18F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients.
    Nanni C; Rubello D; Castellucci P; Farsad M; Franchi R; Toso S; Barile C; Rampin L; Nibale O; Fanti S
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):589-92. PubMed ID: 15726356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia.
    Dhillon T; Palmieri C; Sebire NJ; Lindsay I; Newlands ES; Schmid P; Savage PM; Frank J; Seckl MJ
    J Reprod Med; 2006 Nov; 51(11):879-87. PubMed ID: 17165434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
    Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
    Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.